Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Gorden, D Lee ^a,c   Ivanova, Pavlina T ^b   Myers, David S ^b   McIntyre, J Oliver ^a   VanSaun, Michael N ^a,c   Wright, J Kelly ^c   Matrisian, Lynn M ^a   Brown, H Alex ^b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; LIVER EXTRACT; PHOSPHATIDYLINOSITOL; PHOSPHOLIPID; GLYCEROPHOSPHOLIPID; LIPID;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; LIPID COMPOSITION; LIPID LIVER LEVEL; LIPIDOMICS; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MASS SPECTROMETRY; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PATHOGENESIS; ADOLESCENT; AGED; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; FATTY LIVER; FEMALE; LIPID METABOLISM; LIVER; METABOLISM; MIDDLE AGED; PATHOLOGY; SPECIES DIFFERENCE;

MURINAE; MUS;

ADOLESCENT; ADULT; AGED; ANIMALS; DIGLYCERIDES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FATTY LIVER; FEMALE; GLYCEROPHOSPHOLIPIDS; HUMANS; LIPID METABOLISM; LIPIDS; LIVER; MALE; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; MIDDLE AGED; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 79961211515     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022775     Document Type: Article

References (35)

1. Farrell GC, Larter CZ, (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 (2) Suppl 1: S99-S112.
2. Hjartaker A, Langseth H, Weiderpass, E, (2008) Obesity and diabetes epidemics: cancer repercussions. Adv Exp Med Biol 630: 72-93.
3. Roden M, (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab2 (6): 335-348.
4. Harmeet M, Gores, GJ, (2008) Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease 28 (4): 360-369.
5. Li Z, Agellon LB, Allen TM, Umeda M, Jewell L, al et, (2006) The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis. Cell Metabol 3: 321-331.
6. Kotronen A, Seppanen-Laakso T, Westerbacka J, Kiviluoto T, Arola J, et al. (2009) Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver. Diabetes 58: 203-208.
7. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, et al. (1995) Effects of the obese gene product on body weight regulation in ob/ob mice. Science 269: 540-543.
8. Anstee QM, Goldin RD, (2006) Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87 (1): 1-16.
9. Yetukuri L, Katajamaa M, Medina-Gomez G, Seppänen-Laakso T, Vidal-Puig A, (2007) Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis. BMC Systems Biology 1:article 12.
10. Rouzer CA, Ivanova PT, Byrne MO, Milne SB, Marnett LJ, al et, (2006) Lipid profiling reveals arachidonate deficiency in RAW264.7 cells: Structural and functional implications. Biochemistry 45: 14795-14808.
11. Ivanova PT, Milne SB, Byrne MO, Xiang Y, Brown HA, (2007) Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. Meth Enzymol 432: 21-57.
12. Milne S, Ivanova P, Forrester J, Brown HA, (2006) Lipidomics: An analysis of cellular lipids by ESI-MS. Methods 39: 92-103.
13. Callender HL, Forrester JS, Ivanova P, Preininger A, Milne S, al et, (2007) Quantification of diacylglycerol species from cellular extracts by electrospray ionization mass spectrometry using a linear regression algorithm. Anal Chem 79: 263-272.
14. VanSaun MN, Lee IK, Washington K, Matrisian LM, Gorden DL, (2009) High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model. Amer J Pathol 175 (1): 355-364.
15. Ivanova PT, Milne SB, Brown HA, (2010) Identification of atypical ether-linked glycerophospholipid species in macrophages by mass spectrometry. J Lipid Res 51: 1581-1590.
16. Rouzer CA, Ivanova PT, Byrne MO, Brown HA, Marnett LJ, (2007) Lipid profiling reveals glycerophospholipid remodeling in zymosan-stimulated macrophages. Biochemistry 46: 6026-6042.
17. Milne SB, Ivanova PT, Armstrong MD, Myers DS, Lubarda J, et al. (2008) Dramatic differences in the roles in lipid metabolism of two isoforms of diacylglycerol kinase. Biochemistry 47: 9372-9379.
18. Rappley I, Myers DS, Milne SB, Ivanova PT, LaVoie MJ, et al. (2009) Lipidomics profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with α-synuclein genotype. J Neurochem 111 (1): 15-25.
19. Han X, Gross RW, (2005) Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev 24 (3): 367-412.
20. Woods AS, Jackson SN, (2006) Brain tissue lipidomics: Direct probing using matrix-assisted laser desorption/ionization mass spectrometry. AAPS Journal 8 (2): E391-E395.
21. Mattila I, Seppänen-Laakso T, Suortti T, Orešič M, (2008) Application of lipidomics and metabolomics in the study of adipose tissue. Meth Mol Biol 456: 123-130.
22. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, al et, (2007) A Lipidomic Analysis of Nonalcoholic Fatty Liver Disease. Hepatology 1081-1090.
23. Dobrzyn P, Ntambi JM, Dobrzyn A, (2008) Stearoyl-CoA desaturase: A novel control point of lipid metabolism and insulin sensitivity. Eur J Lipid Sci Technol110: 93-100.
24. Cascales C, Mangiapane EH, Brindley DN, (1984) Oleic acid promotes the activation and translocation of phosphatidate phosphohydrolase from the cytosol to particulate fractions of isolated rat hepatocytes. Biochem J 219: 911-916.
25. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, et al. (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50: 1827-1838.
26. Larter CZ, Yeh MM, Haigh WJ, Williams J, Brown S, al et, (2008) Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways. J Hepatol 48: 638-647.
27. van Ginneken V, Verhey E, Poelmann R, Ramakers R, Willems van Dijk K, H, et al. (2007) Metabolomics (liver and blood profiling) in a mouse model in response to fasting: A study of hepatic steatosis. Biochim Biophys Acta 177: 1263-1270.
28. Day CP, James OF, (1998) Steatohepatitis: a tale of two "hits". Gastroenterology 114: 8842-8845.
29. Koteish A, Mae Diehl A, (2002) Animal models of steatohepatitis. Best Pract Res Clin Gatroenterology16: 679-690.
30. Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, et al. (2007) Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metabol 6: 69-78.
31. Bishop WR, Bell RM, (1988) Functions of diacylglycerol in glycerolipids metabolism, signal transduction and cellular transformation. Oncogene Res 2: 205-218.
32. Nishizuka Y, (1995) Protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496.
33. Deacon EM, Pettitt TR, Webb P, Cross T, Chahai H, (2002) Generation of Diacylglycerol Molecular Species Through Cell Cycle: a role for 1-stearoyl, 2-arachidonyl glycerol in the activation of nuclear protein kinase C-ßII at G2/M. J Cell Science 115: 983-989.
34. Villanueva CJ, Monetti M, Shih M, Zhou, Watkins SM, et al. (2009) Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology 50 (2): 434-442.
35. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, et al. (2008) Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis. Hepatology 47 (2): 625-635.